Evidence map›Paper›PMID 34464159›Full record

ArticleJCO oncology practice2022

Determinants of Risk-Aligned Bladder Cancer Surveillance-Mixed-Methods Evaluation Using the Tailored Implementation for Chronic Diseases Framework.

Florian R Schroeck, A Aziz Ould Ismail, Grace N Perry, David A Haggstrom, Steven L Sanchez, DeRon R Walker, Jeanette Young, Susan Zickmund, Lisa Zubkoff

Open access · bronzeAbstract read
In one paragraph

Article in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Florian R SchroeckFrom the White River Junction VA Medical Center, White River Junction, VT.ORCID 0000-0002-1860-2611
A Aziz Ould IsmailFrom the White River Junction VA Medical Center, White River Junction, VT.
Grace N PerryDepartment of Medicine, University of Utah, Salt Lake City, UT.
David A HaggstromVA HSR&D Center for Health Information and Communication, Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, IN.ORCID 0000-0003-3637-6950
Steven L SanchezVA HSR&D Center for Health Information and Communication, Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, IN.
DeRon R WalkerVA HSR&D Center for Health Information and Communication, Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, IN.
Jeanette YoungVA Salt Lake City Health Care System, Salt Lake City, UT.
Susan ZickmundDepartment of Medicine, University of Utah, Salt Lake City, UT.
Lisa ZubkoffBirmingham/Atlanta VA Geriatric Research Education and Clinical Center (GRECC), Department of Veterans Affairs, Birmingham, AL.
Richard L. Roudebush VA Medical Center · USUniversity of Utah · USDartmouth College · USRegenstrief Institute · USUniversity of Alabama at Birmingham · USVA Salt Lake City Healthcare System · USWhite River Junction VA Medical Center · US

Funding

Implementing Risk-aligned Bladder Cancer SurveillanceI01HX002780 · VA · WHITE RIVER JUNCTION VA MEDICAL CENTER · PI SCHROECK, FLORIAN R · 2020 to 2023
–
HSRD VA I01 HX002780
6 · The paper itself

Abstract

purposeFor many patients with cancer, the frequency of surveillance after primary treatment depends on the risk for cancer recurrence or progression. Lack of risk-aligned surveillance means too many unnecessary surveillance procedures for low-risk patients and not enough for high-risk patients. Using bladder cancer as an example, we examined whether practice determinants differ between Department of Veterans Affairs sites where risk-aligned surveillance was more (risk-aligned sites) or less common (need improvement sites).

methodsWe used our prior quantitative data to identify two risk-aligned sites and four need improvement sites. We performed semistructured interviews with 40 Veterans Affairs staff guided by the Tailored Implementation for Chronic Diseases framework that were deductively coded. We integrated quantitative data (risk-aligned site

resultsThere were 14 participants from risk-aligned sites and 26 participants from need improvement sites. Irrespective of site type, we found a lack of knowledge on guideline recommendations. Additional salient determinants at need improvement sites were a lack of resources ("the next available without overbooking is probably seven to eight weeks out") and an absence of routines to incorporate risk-aligned surveillance ("I have my own guidelines that I've been using for 35 years").

conclusionKnowledge, resources, and lack of routines were salient barriers to risk-aligned bladder cancer surveillance. Implementation strategies addressing knowledge and resources can likely contribute to more risk-aligned surveillance. In addition, reminders for providers to incorporate risk into their surveillance plans may improve their routines.

Indexed as

Urinary Bladder NeoplasmsChronic DiseaseHumans

Identifiers

PMID34464159
PMCPMC8835627
OpenAlexW3197141342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.